Table 1 Baseline characteristics for sex in unmatched and matched cohort (Matched variables are marked bold)
From: Impact of sex in stroke thrombolysis: a coarsened exact matching study
Unmatched | Matched | |||||
|---|---|---|---|---|---|---|
Female | Male | P | Female | Male | P § | |
N | 668 | 723 | 502 | 436 | ||
Age* | 75.3 (12.1) | 68.8 (12.7) | <0.001 | 74.4 (11.0) | 74.3 (10.9) | 0.939 |
NIHSS † | 12 (7; 17) | 10 (6; 15) | <0.001 | 12 (7; 17) | 12 (6; 17) | 0.506 |
Hemisphere, left ‡ | 402 (60.2%) | 412 (57.0%) | 0.231 | 317 (63.1%) | 275 (63.1%) | >0.999 |
Hypertension ‡ | 555 (83.1%) | 565 (78.1%) | 0.021 | 433 (86.3) | 376 (86.3%) | >0.999 |
Diabetes ‡ | 170 (25.4%) | 188 (26.0%) | 0.854 | 106 (21.1%) | 92 (21.1%) | >0.999 |
Atrial fibrillation ‡ | 272 (40.7%) | 185 (25.6%) | <0.001 | 185 (36.9%) | 161 (36.9%) | >0.999 |
Current smoker ‡ | 64 (9.6%) | 146 (20.2%) | <0.001 | 33 (6.6%) | 29 (6.6%) | >0.999 |
CHD ‡ | 114 (17.1%) | 188 (26.0%) | <0.001 | 67 (13.3%) | 58 (13.3%) | >0.999 |
Previous Stroke ‡ | 135 (20.2%) | 155 (21.4%) | 0.597 | 64 (12.7%) | 56 (12.7%) | >0.999 |
TTT [min]† | 140 (105; 180) | 140 (105; 180) | 0.615 | 140 (105; 180) | 140 (110; 180) | 0.504 |
Hyperlipidemia‡ | 195 (29.2%) | 265 (35.4%) | 0.014 | 142 (28.3%) | 115 (26.3%) | 0.557 |
Statin use‡ | 137 (20.5%) | 202 (27.9%) | 0.001 | 103 (20.5%) | 96 (22.0%) | 0.576 |
Antithrombotics‡ | 298 (44.6%) | 340 (47%) | 0.389 | 212 (42.2%) | 216 (49.6%) | 0.026 |
OAC‡ | 44 (6.6%) | 31 (4.3%) | 0.074 | 27 (5.4%) | 21 (4.7%) | 0.767 |
Systolic BP [mmHg]† | 160.6 (22.1) | 159.1 (22.1) | 0.202 | 161.5 (21.0) | 160.3 (22.5) | 0.408 |
Diastolic BP [mmHg]† | 86.1 (16.0) | 88.2 (15.1) | 0.009 | 86.1 (15.6) | 86.3 (15.5) | 0.856 |
Glucose [mg/dl]† | 121 (105; 148) | 120(105; 147) | 0.434 | 120 (105; 147) | 121 (106; 144) | 0.706 |
Platelet [count/nl]† | 263 (215; 313) | 233 (193; 283) | <0.001 | 266 (216; 313) | 234 (192; 277) | <0.001 |